v3.26.3
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (1,938) $ (6,407)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2 66
Unrealized loss on foreign currency remeasurement 0 13
Stock-based compensation expense 312 2,626
Change in fair value of warrant liabilities (880) 0
Interest income (410) 0
Share of earnings (loss) of joint venture 28 (6)
Change in operating assets and liabilities:    
Prepaid expenses and other current assets 232 299
R&D tax incentive 3,419 (364)
Trade and other payables (244) (5,390)
Net cash provided by (used in) operating activities 521 (9,163)
Cash flows from investing activities:    
Purchase of property, plant and equipment 0 (2)
Investment of joint venture (54) (40)
Net cash used in investing activities (54) (42)
Cash flows from financing activities:    
Proceeds from share issuance 0 69,465
Share issuance costs 0 (2,288)
Net cash provided by financing activities 0 67,177
Effect of exchange rate changes on cash and cash equivalents 89 269
Net increase in cash, cash equivalents, and restricted cash before exchange rate movements 467 57,972
Cash and cash equivalents, and restricted cash at beginning of period 67,711 15,039
Cash and cash equivalents, and restricted cash at end of period $ 68,267 $ 73,280